Ensysce Biosciences (ENSC)
0.46
+0.02 (4.55%)
Upcoming Events
Latest Headlines
Ensysce Biosciences Announces Upcoming Conference and Industry Event Participation
September 2, 2026 8:32 AM - StreetInsider
Ensysce completes enrollment in final stage of opioid study
August 31, 2026 8:32 AM - StreetInsider
Ensysce Biosciences Completes Final Phase of PF614-MPAR-102 Clinical Study
August 31, 2026 8:31 AM - StreetInsider
Form 8-K Ensysce Biosciences, For: Aug 25
August 25, 2026 5:12 PM - SEC Filing
Form 8-K Ensysce Biosciences, For: Aug 24
August 24, 2026 5:14 PM - SEC Filing
Form D Ensysce Biosciences,
August 20, 2026 2:14 PM - SEC Filing
Ensysce Biosciences to Showcase "A New Era in Pain Therapeutics" at PAINWeek 2026 Symposium
August 20, 2026 8:01 AM - StreetInsider
Form SCHEDULE 13D/A Ensysce Biosciences, Filed by: GOWER BOB G
August 18, 2026 12:31 PM - SEC Filing
Form 4 Ensysce Biosciences, For: Apr 23 Filed by: GOWER BOB G
August 18, 2026 6:06 AM - SEC Filing
Form 10-Q Ensysce Biosciences, For: Jun 30
August 13, 2026 4:33 PM - SEC Filing
Form 8-K Ensysce Biosciences, For: Aug 13
August 13, 2026 4:20 PM - SEC Filing
Ensysce Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 13, 2026 4:15 PM - StreetInsider
Form 3 Ensysce Biosciences, For: Aug 05 Filed by: Morrison James William
August 10, 2026 4:06 PM - SEC Filing
Form 8-K/A Ensysce Biosciences, For: Aug 05
August 6, 2026 3:45 PM - SEC Filing
Why Investors Are Watching These Healthcare Movers
August 6, 2026 12:32 PM - StreetInsider
Form 8-K Ensysce Biosciences, For: Aug 05
August 6, 2026 8:21 AM - SEC Filing
Ensysce Biosciences acquires Cy Biopharma with up to $77M financing
August 6, 2026 8:01 AM - StreetInsider
Ensysce Biosciences Announces Acquisition of Cy Biopharma and up to $77 Million Private Financing
August 6, 2026 8:01 AM - StreetInsider
Form 8-K Ensysce Biosciences, For: Jul 15
July 15, 2026 4:16 PM - SEC Filing
Ensysce gets $5.3M final installment of $15M NIDA grant
July 14, 2026 8:01 AM - StreetInsider
Ensysce Biosciences Awarded $5.3 Million Installment in NIDA Funding Completing Multi-Year $15 Million Federal Grant
July 14, 2026 8:01 AM - StreetInsider
Form EFFECT Ensysce Biosciences,
June 29, 2026 6:03 AM - SEC Filing
Ensysce Biosciences begins final phase of opioid overdose study
June 26, 2026 8:02 AM - StreetInsider
Ensysce Biosciences Enrolls First Patient in Final Phase of PF614-MPAR-102 Clinical Study
June 26, 2026 8:01 AM - StreetInsider
Full Article List
